Caren van Roekel

286 Chapter 10 73. Ahmadzadehfar H, Muckle M, Sabet A, Wilhelm K, Kuhl C, Biermann K, et al. The significance of bremsstrahlung SPECT/ CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects. Eur J Nucl Med Mol Im. 2011. Epub 2011/10/07. 74. Wang XD, Yang RJ, Cao XC, Tan J, Li B. Dose delivery estimated by bremsstrahlung imaging and partition model correlated with response following intra-arterial radioembolization with 32P-glass microspheres for the treatment of hepatocellular carcinoma. J Gastrointest Surg. 2010;14 (5):858- 66. Epub 2010/03/13. 75. Gates VL, Esmail AA, Marshall K, Spies S, Salem R. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med. 2011;52(1):72-6. Epub 2010/12/15. 76. Pasciak AS, Abiola G, Liddell RP, Crookston N, Besharati S, Donahue D, et al. The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure. Eur J Nucl Med Mol Im. 2020;47(4):816-27. Epub 2019/11/20. 77. Riaz A, Gates VL, Atassi B, Lewandowski RJ, Mulcahy MF, Ryu RK, et al. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys. 2011;79(1):163-71. Epub 2010/04/28. 78. Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Im. 2011;38(7):1393- 406. Epub 2011/04/16. 79. Smits ML, Elschot M, Sze DY, Kao YH, Nijsen JF, Iagaru AH, et al. Radioembolization dosimetry: the road ahead. Cardiovasc Interv Radiol. 2015;38(2):261-9. Epub 2014/12/30. 80. Smits MLJ, Nijsen JFW, van den Bosch MAAJ, Lam MGEH, Vente MAD, Mali WPTM, et al. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. Lancet Oncol. 2012;13(10):1025-34. 81. Ho S, Lau WY, Leung TWT, Chan M, Ngar YK, Johnson PC, et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours Eur J Nucl Med. 1996;23:947-52. 82. Elschot M, Smits ML, Nijsen JF, Lam MG, Zonnenberg BA, van den Bosch MA, et al. Quantitative Monte Carlo-based holmium-166 SPECT reconstruction. Medical physics. 2013;40(11):112502. Epub 2013/12/11. 83. Garin E, Rolland Y, Laffont S, Edeline J. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres. Eur J Nucl Med Mol Im. 2016;43(3):559-75. Epub 2015/09/05.